skip to main content

ACE inhibitor in diabetes monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateEndocrine TherapeuticsACE inhibitor in diabetes monitoringGPhC CRA

A patient with type 2 diabetes and albuminuria is starting ramipril. The nurse asks what should be checked after initiation. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CSerum creatinine, estimated glomerular filtration rate and potassium

Renin-angiotensin system blockers can alter renal function and potassium. The best answer addresses the key safety, legal or pharmaceutical care issue in the vignette. The other options would either delay appropriate care, create a new risk, or fail to resolve the issue. This is consistent with the cited UK reference for safe pharmacy practice.

Reference: BNF; NICE CKS